eMedicine Specialties > Emergency Medicine > Genitourinary

Renal Calculi: Follow-up

Author: Sandy Craig, MD, Adjunct Associate Professor, Department of Emergency Medicine, University of North Carolina at Chapel Hill, Carolinas Medical Center
Contributor Information and Disclosures

Updated: Oct 29, 2009

Follow-up

Further Inpatient Care

  • Admission rate for patients with acute renal colic is approximately 20%. Three absolute indications for admission are (1) infected hydronephrosis, (2) unrelenting pain or vomiting despite analgesics and antiemetics, and (3) dehydration.
    • Infected hydronephrosis is defined as UTI proximal to an obstructing stone. Infected hydronephrosis mandates admission for antibiotics and prompt drainage.
      • Midstream urine culture and sensitivity was a poor predictor of infected hydronephrosis in one series, being positive in only 30% of cases.27
      • The clinical presentation of infected hydronephrosis is variable. Pyuria (>5 WBC/hpf) is almost always present but not diagnostic of proximal infection. In one small series of 23 patients with infected hydronephrosis, the temperature was higher than 38°C in 15 patients, the peripheral WBC count was more than 10 X 109/L in 13 patients, and the creatinine level was greater than 1.3 mg/dL in 12 patients.28
      • Renal ultrasonography or helical CT may distinguish pyonephrosis from simple hydronephrosis by demonstrating a fluid-fluid level in the renal pelvis (urine on top of purulent debris). In 2 small studies, the ultrasonographic sensitivity for pyonephrosis was found to be 62-67%. CT sensitivity for pyonephrosis has not been reliably determined.29,30 The emergency physician must maintain a high index of suspicion.31 Antibiotics should cover E coli and Staphylococcus, Enterobacter, Proteus, and Klebsiella species.
      • In another small study of 38 patients with hydronephrosis, 16 had infected hydronephrosis and 22 had sterile hydronephrosis. Ultrasonography alone detected 6 of 16 cases of pyonephrosis, a sensitivity of 38%. Using a cutoff value of 3 mg/dL for C-reactive protein and 100 mm/h for erythrocyte sedimentation rate, the diagnostic accuracy of detecting infected hydronephrosis and pyonephrosis increased to 97%.32
    • Patients with complete obstruction, perinephric urine extravasation, a solitary kidney, renal transplant, renal failure, or pregnancy, and those with a poor social support system, also should be considered for admission, especially if rapid urologic follow-up is not reliably available.
    • A stone less than 4 mm in diameter has an 80% chance of spontaneous passage; this falls to 20% for stones larger than 8 mm in diameter. The urologist may choose to admit a patient with a ureteral stone larger than 6 mm because of low likelihood of spontaneous passage.
  • About 15-20% of patients require invasive intervention due to stone size, continued obstruction, infection, or intractable pain. Several techniques are available to the urologist when the stone fails to pass spontaneously.33
    • Extracorporeal shock wave lithotripsy (ESWL) utilizes an underwater energy wave focused on the stone to shatter it into passable fragments. Approximately 70% of stones can be treated with ESWL alone. This technique is especially suitable for stones that are smaller than 2 cm and lodged in the upper or middle calyx. Anesthesia or sedation is required. ESWL is contraindicated in pregnancy, untreatable bleeding disorders, patients weighing more than 300 lb, tightly impacted or cystine stones, or in cases of ureteral obstruction distal to the stone.
    • Ureteroscopy is especially suitable for removal of stones that are 1-2 cm, lodged in the lower calyx or below, cystine stones, and high attenuation ("hard") stones. Stones smaller than 5 mm in diameter generally are retrieved using a stone basket, whereas tightly impacted stones or those larger than 5 mm are manipulated proximally for ESWL or are fragmented using an endoscopic direct-contact fragmentation device.
    • Percutaneous nephrolithotomy involves entering the renal pelvis percutaneously using the Seldinger technique after ultrasonography or fluoroscopic localization. Renal calyces, pelvis, and proximal ureter can be examined and stones extracted with or without prior fragmentation. This technique is especially useful for stones larger than 2 cm in diameter. A percutaneous nephrostomy can be used as an emergency procedure to relieve obstruction in a high-risk patient in whom other treatments are not feasible.34
    • Open nephrostomy rarely is used since the development of ESWL and endoscopic and percutaneous techniques. Open nephrostomy now constitutes only 1-2% of all interventions. Disadvantages include longer hospitalization, longer convalescence, and increased requirements for blood transfusion.

Further Outpatient Care

  • Patients who do not meet admission criteria may be discharged from the ED in anticipation that the stone will pass spontaneously at home.
    • Arrange for follow-up with a urologist in 2-3 days. Patients should be told to return immediately for fever, uncontrolled pain, or vomiting.
    • Patients should be discharged with a urine strainer and encouraged to submit any recovered calculi to a urologist for chemical analysis.
    • Follow-up for patients with first-time incidence of stones should consist of stone analysis and abbreviated metabolic evaluation to rule out hyperparathyroidism, renal tubular acidosis, and chronic infection with urea-splitting bacteria.
    • Patients with recurrent ureterolithiasis should undergo a more thorough metabolic evaluation. Patients with recurrent stones who undergo thorough metabolic evaluation and specific therapy enjoy a remission rate in excess of 80% and can decrease the rate of stone formation by 90%. A stone chemical analysis together with serum and appropriate 24-hour urine metabolic tests can identify the etiology in more than 95% of patients. A typical 24-hour urine determination should include urinary volume, pH, specific gravity, calcium, citrate, magnesium, oxalate, phosphate, and uric acid. Most common findings are hypercalciuria, hyperuricosuria, hyperoxaluria, hypocitraturia, and low urinary volume. Therefore, the emergency physician should encourage urologic follow-up.

Inpatient & Outpatient Medications

  • Discharge on an oral analgesic and an antiemetic if needed. No studies exist that demonstrate superiority of one oral analgesic over another. Typical choices include agents such as hydrocodone, oxycodone, meperidine, or oral anti-inflammatory agents.
  • Medical therapies to aid in passage of a stone have been studied. Multiple randomized controlled prospective studies show that outpatient treatment with sustained-release nifedipine 30 mg/d plus prednisolone 25 mg/d or tamsulosin 0.4 mg/d decreases the time to spontaneous passage of the stone; increases the overall spontaneous expulsion rate; and decreases the need for analgesics, hospitalization, and endoscopic intervention.21,22,23

Deterrence/Prevention

  • Patients with recurrent nephrolithiasis traditionally have been instructed to drink 8 glasses of fluid daily to maintain adequate hydration and decrease chance of urinary supersaturation with stone-forming salts.
  • Prospective studies suggest that daily consumption of coffee, tea, beer, or wine decreases risk of stone formation, while daily consumption of apple or grapefruit juice increases risk of stone formation.35

Complications

  • Infected hydronephrosis is the most deadly complication because the presence of infection adjacent to the highly vascular renal parenchyma places the patient at risk for rapidly progressive sepsis and death.
  • Calyceal rupture with perinephric urine extravasation due to high intracaliceal pressures occasionally is seen and usually is treated conservatively.
  • Complete ureteral obstruction may occur in patients with tightly impacted stones. This is best diagnosed via IVP and is not discernible on noncontrast CT scan. Patients with 2 healthy kidneys can tolerate several days of complete unilateral ureteral obstruction without long-term effects on the obstructed kidney. If a patient with complete obstruction is well hydrated and pain and vomiting are well controlled, the patient can be discharged from the ED with urologic follow-up within 1-2 days.

Prognosis

  • Approximately 80% of ureteral stones pass spontaneously without hospitalization or invasive intervention.
  • Approximately 20% of patients require hospitalization due to dehydration, continued pain or vomiting, or inability to pass the stone spontaneously.
  • Recurrence rates after an initial episode of ureterolithiasis are 14%, 35%, and 52% at 1, 5, and 10 years, respectively. Risk of recurrence can be reduced drastically by specific medical therapy based on analysis of the stone and serum and urine metabolic profiles.

Patient Education

Miscellaneous

Medicolegal Pitfalls

  • Failure to diagnose or delay in diagnosing symptomatic AAA: Pain of a leaking abdominal aortic aneurysm often is misdiagnosed initially as renal colic.
  • In one series of 134 patients with symptomatic AAA presenting to the ED, the following statistics were reported:36
    • Eighteen percent had an initial misdiagnosis of nephrolithiasis.
    • All were older than 60 years of age and none had a prior history of renal calculi.
    • Eighty percent had a pulsatile mass noted by at least one examiner.
    • Forty-three percent had microhematuria on urinalysis.
    • Delay of diagnosis of AAA in the ED was associated with higher mortality and morbidity rates than in the group who received the correct diagnosis promptly.
  • Failure to diagnose UTI proximal to a ureteral stone and to seek urgent urologic intervention in these patients
 


More on Renal Calculi

Overview: Renal Calculi
Differential Diagnoses & Workup: Renal Calculi
Treatment & Medication: Renal Calculi
Follow-up: Renal Calculi
Multimedia: Renal Calculi
References

References

  1. Worcester EM, Coe FL. Nephrolithiasis. Prim Care. Jun 2008;35(2):369-91, vii. [Medline].

  2. Chandhoke PS. Evaluation of the recurrent stone former. Urol Clin North Am. Aug 2007;34(3):315-22. [Medline].

  3. Borghi L, Schianchi T, Meschi T, Guerra A, Allegri F, Maggiore U, et al. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med. Jan 10 2002;346(2):77-84. [Medline].

  4. Russinko PJ, Agarwal S, Choi MJ, Kelty PJ. Obstructive nephropathy secondary to sulfasalazine calculi. Urology. Oct 2003;62(4):748. [Medline].

  5. Thomas A, Woodard C, Rovner ES, Wein AJ. Urologic complications of nonurologic medications. Urol Clin North Am. Feb 2003;30(1):123-31. [Medline].

  6. Whelan C, Schwartz BF. Bilateral guaifenesin ureteral calculi. Urology. Jan 2004;63(1):175-6. [Medline].

  7. Bove P, Kaplan D, Dalrymple N, et al. Reexamining the value of hematuria testing in patients with acute flank pain. J Urol. Sep 1999;162(3 Pt 1):685-7. [Medline].

  8. Press SM, Smith AD. Incidence of negative hematuria in patients with acute urinary lithiasis presenting to the emergency room with flank pain. Urology. May 1995;45(5):753-7. [Medline].

  9. Lindqvist K, Hellstrom M, Holmberg G, et al. Immediate versus deferred radiological investigation after acute renal colic: a prospective randomized study. Scand J Urol Nephrol. 2006;40(2):119-24. [Medline].

  10. Dundee P, Bouchier-Hayes D, Haxhimolla H, et al. Renal tract calculi: comparison of stone size on plain radiography and noncontrast spiral CT scan. J Endourol. Dec 2006;20(12):1005-9. [Medline].

  11. Jindal G, Ramchandani P. Acute flank pain secondary to urolithiasis: radiologic evaluation and alternate diagnoses. Radiol Clin North Am. May 2007;45(3):395-410, vii. [Medline].

  12. Neville A, Hatem SF. Renal medullary carcinoma: unsuspected diagnosis at stone protocol CT. Emerg Radiol. Sep 2007;14(4):245-7. [Medline].

  13. Kishore TA, Pedro RN, Hinck B, Monga M. Estimation of size of distal ureteral stones: noncontrast CT scan versus actual size. Urology. Oct 2008;72(4):761-4. [Medline].

  14. Dusseault BN, Croce KJ, Pais VM Jr. Radiographic characteristics of sulfadiazine urolithiasis. Urology. Apr 2009;73(4):928.e5-6. [Medline].

  15. Pais VM Jr, Payton AL, LaGrange CA. Urolithiasis in pregnancy. Urol Clin North Am. Feb 2007;34(1):43-52. [Medline].

  16. Cauni V, Multescu R, Geavlete P, Geavlete B. [The importance of Doppler ultrasonographic evaluation of the ureteral jets in patients with obstructive upper urinary tract lithiasis]. Chirurgia (Bucur). Nov-Dec 2008;103(6):665-8. [Medline].

  17. Sudah M, Vanninen R, Partanen K, et al. MR urography in evaluation of acute flank pain: T2-weighted sequences and gadolinium-enhanced three-dimensional FLASH compared with urography. Fast low-angle shot. AJR Am J Roentgenol. Jan 2001;176(1):105-12. [Medline].

  18. Springhart WP, Marguet CG, Sur RL, et al. Forced versus minimal intravenous hydration in the management of acute renal colic: a randomized trial. J Endourol. Oct 2006;20(10):713-6. [Medline].

  19. Labrecque M, Dostaler LP, Rousselle R, et al. Efficacy of nonsteroidal anti-inflammatory drugs in the treatment of acute renal colic. A meta-analysis. Arch Intern Med. Jun 27 1994;154(12):1381-7. [Medline].

  20. Larkin GL, Peacock WF 4th, Pearl SM, et al. Efficacy of ketorolac tromethamine versus meperidine in the ED treatment of acute renal colic. Am J Emerg Med. Jan 1999;17(1):6-10. [Medline].

  21. Dellabella M, Milanese G, Muzzonigro G. Efficacy of tamsulosin in the medical management of juxtavesical ureteral stones. J Urol. Dec 2003;170(6 Pt 1):2202-5. [Medline].

  22. Dellabella M, Milanese G, Muzzonigro G. Randomized trial of the efficacy of tamsulosin, nifedipine and phloroglucinol in medical expulsive therapy for distal ureteral calculi. J Urol. Jul 2005;174(1):167-72. [Medline].

  23. Porpiglia F, Ghignone G, Fiori C, et al. Nifedipine versus tamsulosin for the management of lower ureteral stones. J Urol. Aug 2004;172(2):568-71. [Medline].

  24. [Best Evidence] Singh A, Alter HJ, Littlepage A. A systematic review of medical therapy to facilitate passage of ureteral calculi. Ann Emerg Med. Nov 2007;50(5):552-63. [Medline].

  25. Beach MA, Mauro LS. Pharmacologic expulsive treatment of ureteral calculi. Ann Pharmacother. Jul-Aug 2006;40(7-8):1361-8. [Medline].

  26. Ferre RM, Wasielewski JN, Strout TD, Perron AD. Tamsulosin for ureteral stones in the emergency department: a randomized, controlled trial. Ann Emerg Med. Sep 2009;54(3):432-9, 439.e1-2. [Medline].

  27. Mariappan P, Loong CW. Midstream urine culture and sensitivity test is a poor predictor of infected urine proximal to the obstructing ureteral stone or infected stones: a prospective clinical study. J Urol. Jun 2004;171(6 Pt 1):2142-5. [Medline].

  28. St Lezin M, Hofmann R, Stoller ML. Pyonephrosis: diagnosis and treatment. Br J Urol. Oct 1992;70(4):360-3. [Medline].

  29. Jeffrey RB, Laing FC, Wing VW. Sensitivity of sonography in pyonephrosis: a reevaluation. AJR Am J Roentgenol. Jan 1985;144(1):71-3. [Medline].

  30. Schneider K, Helmig FJ, Eife R. Pyonephrosis in childhood--is ultrasound sufficient for diagnosis?. Pediatr Radiol. 1989;19(5):302-7. [Medline].

  31. Fultz PJ, Hampton WR, Totterman SM. Computed tomography of pyonephrosis. Abdom Imaging. 1993;18(1):82-7. [Medline].

  32. Wu TT, Lee YH, Tzeng WS, et al. The role of C-reactive protein and erythrocyte sedimentation rate in the diagnosis of infected hydronephrosis and pyonephrosis. J Urol. Jul 1994;152(1):26-8. [Medline].

  33. Wen CC, Nakada SY. Treatment selection and outcomes: renal calculi. Urol Clin North Am. Aug 2007;34(3):409-19. [Medline].

  34. Ramakumar S, Segura JW. Renal calculi. Percutaneous management. Urol Clin North Am. Nov 2000;27(4):617-22. [Medline].

  35. Finkielstein VA, Goldfarb DS. Strategies for preventing calcium oxalate stones. CMAJ. May 9 2006;174(10):1407-9. [Medline].

  36. Borrero E, Queral LA. Symptomatic abdominal aortic aneurysm misdiagnosed as nephroureterolithiasis. Ann Vasc Surg. Apr 1988;2(2):145-9. [Medline].

  37. Sidhu R, Bhatt S, Dogra V. Renal Colic. Ultrasound Clinics. Jan 2008;3:159-170.

  38. Venkat A, Piontkowsky DM, Cooney RR, et al. Care of the HIV-positive patient in the emergency department in the era of highly active antiretroviral therapy. Ann Emerg Med. Sep 2008;52(3):274-85. [Medline].

Further Reading

Keywords

kidney stone symptoms, kidney stone causes, kidney stone treatment, renal calculi, kidney stone, renal stone, ureteral calculi, nephrolithiasis, ureterolithiasis, kidney calculi, acute nephrolithiasis

Contributor Information and Disclosures

Author

Sandy Craig, MD, Adjunct Associate Professor, Department of Emergency Medicine, University of North Carolina at Chapel Hill, Carolinas Medical Center
Sandy Craig, MD is a member of the following medical societies: Alpha Omega Alpha and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Medical Editor

David S Howes, MD, Residency Program Director, Professor of Medicine, Section of Emergency Medicine, University of Chicago/Pritzker School of Medicine
David S Howes, MD is a member of the following medical societies: American College of Emergency Physicians, American College of Physicians-American Society of Internal Medicine, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment

Managing Editor

Richard H Sinert, DO, Associate Professor of Emergency Medicine, Clinical Assistant Professor of Medicine, Research Director, State University of New York College of Medicine; Consulting Staff, Department of Emergency Medicine, Kings County Hospital Center
Richard H Sinert, DO is a member of the following medical societies: American College of Physicians and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

CME Editor

John D Halamka, MD, MS, Associate Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center; Chief Information Officer, CareGroup Healthcare System and Harvard Medical School; Attending Physician, Division of Emergency Medicine, Beth Israel Deaconess Medical Center
John D Halamka, MD, MS is a member of the following medical societies: American College of Emergency Physicians, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Chief Editor

Robert E O'Connor, MD, MPH, Professor and Chair, Department of Emergency Medicine, University of Virginia Health System
Robert E O'Connor, MD, MPH is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians, American College of Physician Executives, American Heart Association, American Medical Association, Medical Society of Delaware, National Association of EMS Physicians, Society for Academic Emergency Medicine, and Wilderness Medical Society
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.